Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.08 +0.01 (+0.25%)
As of: Oct 2, 2026 · 3:20 PM EDT

Recursion Pharmaceuticals (RXRX) Short-term Investments (2021 - 2022)

Updated

Recursion Pharmaceuticals' Short-term Investments was $61.56 million in Q2 2022, down 26.0% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Short-term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, Short-term Investments at Recursion Pharmaceuticals came in at $231.45 million.

  • Per Business Quant data, RXRX's Short-term Investments in the three quarters before Q2 2022 was $83.21 million (Q1 2022), $231.45 million (Q4 2021) and $184.19 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Recursion Pharmaceuticals 2.21 Bn -397.37 Mn -3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 61.56 Mn
Mar 31, 2022 83.21 Mn
Dec 31, 2021 231.45 Mn
Sep 30, 2021 184.19 Mn
API Access

Recursion Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=RXRX&period=max&api_key=YOUR_API_KEY